Both sets of approaches have shown promise in studying B-cell cancers, which result from significant clonal expansions of usually one BCR lineage [20], but it is unknown if a similar approach will be informative when studying immune responses to HIV infection. The gene discussed is BCR; the disease is HIV infectious disease.